Marfan syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

Marfan wrist
Marfan thumb sign
Human_ hromosome 15 from NCBI Bookshelf
Marfan Chest
Marfan Patient
Steinberg and_Walker-Murdoch tests
MARFAN ECLIPSE

Marfan syndrome (MFS) is a genetic disorder affecting the body's connective tissue, leading to a variety of symptoms and physical characteristics. Individuals with Marfan syndrome often exhibit a tall and thin physique, elongated arms, legs, fingers, and toes, flexible joints, and scoliosis. The severity and range of symptoms can vary significantly among affected individuals.

Signs and Symptoms[edit | edit source]

Marfan syndrome affects multiple systems within the body, including the skeletal, ocular, cardiovascular, pulmonary, and nervous systems.

Skeletal System[edit | edit source]

  • Elongation of the arms and legs
  • Flexible joints
  • Scoliosis and other spinal deformities
  • Chest deformities, such as pectus excavatum (sunken chest) or pectus carinatum (pigeon chest)

Eyes[edit | edit source]

  • Lens dislocation (Ectopia lentis)
  • Myopia (short-sightedness)
  • Increased risk of retinal detachment

Cardiovascular System[edit | edit source]

  • Mitral valve prolapse
  • Aortic aneurysm and dissection
  • Risk of sudden cardiac arrest

Lungs[edit | edit source]

  • Increased susceptibility to spontaneous pneumothorax (collapsed lung)
  • Sleep apnea

Nervous System[edit | edit source]

  • Dural ectasia, the weakening and expansion of the dural sac surrounding the spinal cord

Genetics[edit | edit source]

Marfan syndrome is primarily caused by mutations in the FBN1 gene, which encodes the fibrillin-1 protein. This protein plays a critical role in the structure and function of connective tissue. Marfan syndrome is an autosomal dominant disorder, meaning a mutation in just one of the two copies of the FBN1 gene is sufficient to cause the disorder. Approximately 75% of cases are inherited from an affected parent, while 25% result from new mutations.

Pathogenesis[edit | edit source]

The mutations in the FBN1 gene lead to the production of abnormal fibrillin-1, disrupting the microfibrils that support and stabilize connective tissues. This disruption affects the strength and elasticity of tissues, contributing to the symptoms of Marfan syndrome.

Marfanoid–progeroid–lipodystrophy syndrome[edit | edit source]

This is a related condition that shares some features with Marfan syndrome but also includes symptoms of progeroid and lipodystrophy syndromes.

Diagnosis[edit | edit source]

Diagnosis of Marfan syndrome is often based on the Ghent criteria, which consider family history, genetic testing, and the presence of specific clinical features in various body systems.

Revised Ghent Nosology[edit | edit source]

The Revised Ghent Nosology provides a framework for diagnosing Marfan syndrome based on a combination of major and minor criteria spanning various organ systems.

Differential Diagnosis[edit | edit source]

It is crucial to differentiate Marfan syndrome from other disorders with similar features, such as Loeys-Dietz syndrome and Ehlers-Danlos syndrome.

Management[edit | edit source]

While there is no cure for Marfan syndrome, management focuses on monitoring and treating symptoms to improve quality of life and prevent complications.

Physical Activity[edit | edit source]

Strenuous exercise is generally discouraged, though specific recommendations may vary based on individual risk factors.

Medication[edit | edit source]

  • Beta blockers like propranolol or atenolol are commonly prescribed.
  • Calcium channel blockers or ACE inhibitors may be alternatives.

Surgery[edit | edit source]

Surgical interventions may be necessary to repair aortic aneurysms or replace heart valves.

Pregnancy[edit | edit source]

Women with Marfan syndrome face increased risks during pregnancy and require close monitoring.

Prognosis[edit | edit source]

With appropriate management, many individuals with Marfan syndrome have a normal life expectancy. Ongoing research continues to improve treatment options and outcomes.

Epidemiology[edit | edit source]

Marfan syndrome affects about 1 in 5,000 to 10,000 people worldwide and occurs equally among males and females across different races and regions.

History[edit | edit source]

The syndrome is named after Antoine Marfan, the French pediatrician who first described the condition in 1896.


Marfan syndrome Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD